{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:03:19Z","timestamp":1761894199955},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf02246060","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T05:29:26Z","timestamp":1132032566000},"page":"99-104","source":"Crossref","is-referenced-by-count":5,"title":["Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures"],"prefix":"10.1007","volume":"119","author":[{"given":"A.","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Fochtmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02246060_CR1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0091-3057(83)90062-X","volume":"19","author":"T Albertson","year":"1983","unstructured":"Albertson T, Joy R, Stark L (1983) Caffeine modification of kindled amygdaloid seizures. Pharmacol Biochem Behav 19:339\u2013343","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246060_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(90)90136-Y","volume":"534","author":"F Angelatou","year":"1990","unstructured":"Angelatou F, Pagonopoulou O, Kostopoulos G (1990) Alterations of A1 adenosine receptors in different mouse brain areas after pentylenetetrazol-induced seizures, but not in the epileptic mutant mouse \u2018tottering\u2019. Brain Res 534:251\u2013256","journal-title":"Brain Res"},{"key":"BF02246060_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0006-2952(92)90257-J","volume":"43","author":"J Baumgold","year":"1992","unstructured":"Baumgold J, Nikodijevic O, Jacobson K (1992) Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding. Biochem Pharmacol 43:889\u2013894","journal-title":"Biochem Pharmacol"},{"key":"BF02246060_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.me.41.020190.001425","volume":"41","author":"N Benowitz","year":"1990","unstructured":"Benowitz N (1990) Clinical pharmacology of caffeine. Annu Rev Med 41:277\u2013288","journal-title":"Annu Rev Med"},{"key":"BF02246060_CR5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/0024-3205(83)90119-4","volume":"32","author":"J Boulenger","year":"1983","unstructured":"Boulenger J, Patel J, Post R, Parma A, Marangos P (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci 32:1135\u20131142","journal-title":"Life Sci"},{"key":"BF02246060_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00165037","volume":"335","author":"R Bruns","year":"1987","unstructured":"Bruns R, Fergus J, Badger E, Bristol J, Santay L, Hartman J, Hays S, Huang C (1987) Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes. Nauyn-Schmiedeberg Arch Pharmacol 335:59\u201363","journal-title":"Nauyn-Schmiedeberg Arch Pharmacol"},{"key":"BF02246060_CR7","first-page":"95","volume":"9","author":"A Calev","year":"1993","unstructured":"Calev A, Fink M, Petrides G, Francis A, Fochtmann L (1993) Caffeine pre-treatment enhances clinical efficacy and reduces cognitive effects of electroconvulsive therapy. Convuls Ther 9:95\u2013100","journal-title":"Convuls Ther"},{"key":"BF02246060_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.1982.tb09161.x","volume":"75","author":"J Carney","year":"1982","unstructured":"Carney J (1982) Effects of caffeine, theophylline, and theobromide on schedule-controlled responding in rats. Br J Pharm 75:451\u2013454","journal-title":"Br J Pharm"},{"key":"BF02246060_CR9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1006\/bbrc.1994.1091","volume":"198","author":"M Castanon","year":"1994","unstructured":"Castanon M, Spevak W (1994) Functional coupling of human adenosine receptors to a ligand-dependent reporter gene system. Biochem Biphys Res Commun 198:626\u2013631","journal-title":"Biochem Biphys Res Commun"},{"key":"BF02246060_CR10","first-page":"69","volume":"26","author":"J Chin","year":"1988","unstructured":"Chin J (1988) Adenosine receptors in brain: neuromodulation and role in epilepsy. Ann Neurol 26:69\u2013698","journal-title":"Ann Neurol"},{"key":"BF02246060_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0024-3205(88)90517-6","volume":"43","author":"O Choi","year":"1988","unstructured":"Choi O, Shamim M, Padgett W, Daly J (1988) Caffeine and theophylline analogs: correlation with behavcioral erffects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 43:387\u2013398","journal-title":"Life Sci"},{"key":"BF02246060_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1528-1157.1981.tb04335.x","volume":"22","author":"N-S Chu","year":"1981","unstructured":"Chu N-S (1981) Caffeine and aminophylline-induced seizures. Epilepsia 22:85\u201394","journal-title":"Epilepsia"},{"key":"BF02246060_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(86)90098-1","volume":"122","author":"A Chweh","year":"1986","unstructured":"Chweh A, Ulloque R, Swinyard E (1986) Benzodiazepine inhibition of 3H-flunitrazepam binding and caffeine-induced seizures in mice. Eur J Pharmacol 122:161\u2013165","journal-title":"Eur J Pharmacol"},{"key":"BF02246060_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1176\/ajp.147.5.579","volume":"147","author":"C Coffey","year":"1990","unstructured":"Coffey C, Figiel G, Weiner R, Saunders W (1990) Caffeine augmentation of ECT. Am J Psychiatry 147:579\u2013585","journal-title":"Am J Psychiatry"},{"key":"BF02246060_CR15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1528-1157.1989.tb05276.x","volume":"301","author":"J-L Daval","year":"1989","unstructured":"Daval J-L, Deckert J, Weiss S, Post R, Marangos P (1989) Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia 301:26\u201333","journal-title":"Epilepsia"},{"key":"BF02246060_CR16","doi-asserted-by":"crossref","unstructured":"Dragunow M (1986) Adenosine: the brain's natural anticonvulsant? Trends Pharm Sci 128\u2013130","DOI":"10.1016\/0165-6147(86)90285-3"},{"key":"BF02246060_CR17","first-page":"31","volume":"249","author":"T Dunwiddie","year":"1989","unstructured":"Dunwiddie T, Fredholm B (1989) Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize neurons in rat hippocampus. J Pharmacol Exp Ther 249:31\u201337","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246060_CR18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.410320504","volume":"32","author":"M During","year":"1992","unstructured":"During M, Spencer D (1992) Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann Neurol 32:618\u2013623","journal-title":"Ann Neurol"},{"key":"BF02246060_CR19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF00207230","volume":"93","author":"I Finn","year":"1987","unstructured":"Finn I, Holtzman S (1987) Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology 93:428\u2013434","journal-title":"Psychopharmacology"},{"key":"BF02246060_CR20","first-page":"321","volume":"30","author":"L Fochtmann","year":"1994","unstructured":"Fochtmann L (1994) Animal studies of electroconvulsive therapy: foundations for future research. Psychopharmacol Bull 30:321\u2013442","journal-title":"Psychopharmacol Bull"},{"key":"BF02246060_CR21","first-page":"185","volume":"9","author":"A Francis","year":"1993","unstructured":"Francis A, Fochtmann L (1993) Sustained downregulation of cortical beta-adrenergic receptor density with maintenance ECS. Convuls Ther 9:185\u2013191","journal-title":"Convuls Ther"},{"key":"BF02246060_CR22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02245072","volume":"115","author":"A Francis","year":"1994","unstructured":"Francis A, Fochtmann L (1994) Caffeine augmentation of electroconvulsive seizures. Psychopharmacology 115:320\u2013324","journal-title":"Psychopharmacology"},{"key":"BF02246060_CR23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0024-3205(89)90550-X","volume":"44","author":"C Gleiter","year":"1989","unstructured":"Gleiter C, Nutt D (1989) Minireview: chronic electroconvulsive shock and neurotransmitter receptors: an update. Life Sci 44:985\u20131006","journal-title":"Life Sci"},{"key":"BF02246060_CR24","first-page":"544","volume":"95","author":"C Gleiter","year":"1988","unstructured":"Gleiter C, Deckert J, Nutt D (1988) Changes in caffeine seizure threshold after electroconvulsive shock. Psychopharmacology 95:544\u2013545","journal-title":"Psychopharmacology"},{"key":"BF02246060_CR25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.1989.tb09168.x","volume":"52","author":"C Gleiter","year":"1989","unstructured":"Gleiter C, Deckert J, Nutt D, Marangos P (1989) Electroconvulsive shock (ECS) and the adenosine neuromodulatory system: effect of single and repeated ECS on the adenosine A1 and A2 receptors, adenylate cyclase, and the adenosine uptake site. J Neurochem 52:641\u2013646","journal-title":"J Neurochem"},{"key":"BF02246060_CR26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410060403","volume":"6","author":"R Gross","year":"1979","unstructured":"Gross R, Ferrendelli J (1979) Effects of reserpine, propranolol, and aminophylline on seizure activity and CNS cyclic nucleotides. Ann Neurol 6:296\u2013301","journal-title":"Ann Neurol"},{"key":"BF02246060_CR27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0361-9230(88)90162-1","volume":"21","author":"M Hawkins","year":"1988","unstructured":"Hawkins M, Dugich M, Porter N, Urbancic M, Radulovacki M (1988) Effects of chronic administration of caffeine on adenosine A1 and A2 receptors in rat brain. Brain Res Bull 21:479\u2013482","journal-title":"Brain Res Bull"},{"key":"BF02246060_CR28","first-page":"62","volume":"256","author":"S Holtzman","year":"1991","unstructured":"Holtzman S, Mante S, Minneman K (1991) Role of adenosine receptors in caffeine tolerance. J Pharmacol Exp Ther 256:62\u201368","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246060_CR29","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1021\/jm00070a007","volume":"36","author":"K Jacobson","year":"1993","unstructured":"Jacobson K, Shi D, Gallo-Rodriguez C, Manning M, Muller C, Daly J, Neumeyer J, Kiriasis L, Pfleiderer W (1993) Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. J Med Chem 36:2639\u20132644","journal-title":"J Med Chem"},{"key":"BF02246060_CR30","first-page":"404","volume":"347","author":"B Johansson","year":"1993","unstructured":"Johansson B, Ahlberg S, Van der Ploeg I, Brene S, Lindefors N, Persson H, Fredholm B (1993) Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and mRNA levels in rat brain. Nauyn Schmiedeberg Arch Pharmacol 347:404\u2013414","journal-title":"Nauyn Schmiedeberg Arch Pharmacol"},{"key":"BF02246060_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0006-8993(84)90694-2","volume":"321","author":"K Lee","year":"1984","unstructured":"Lee K, Schubert P, Heinemann U (1984) The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant. Brain Res 321:160\u2013164","journal-title":"Brain Res"},{"issue":"Suppl 4","key":"BF02246060_CR32","first-page":"453","volume":"9","author":"B Lerer","year":"1986","unstructured":"Lerer B, Shapira B, Drexler H, Calev A, Newman M (1986) Pharmacological manipulation of ECT-induced seizure duration. Clin Neuropharmacol 9 ([Suppl 4]):453\u2013455","journal-title":"Clin Neuropharmacol"},{"key":"BF02246060_CR33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0149-7634(85)90020-X","volume":"9","author":"P Marangos","year":"1985","unstructured":"Marangos P, Boulenger J (1985) Basic and clinical aspects of adenosinergic neuromodulation. Neurosci Biobehav Rev 9:421\u2013430","journal-title":"Neurosci Biobehav Rev"},{"key":"BF02246060_CR34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0024-3205(84)90207-8","volume":"34","author":"P Marangos","year":"1984","unstructured":"Marangos P, Boulenger J, Patel J (1984) Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. Life Sci 34:899\u2013907","journal-title":"Life Sci"},{"key":"BF02246060_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(82)90563-5","volume":"82","author":"T Murray","year":"1982","unstructured":"Murray T (1982) Upregulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol 82:113\u2013114","journal-title":"Eur J Pharmacol"},{"key":"BF02246060_CR36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(84)90670-X","volume":"291","author":"M Newman","year":"1984","unstructured":"Newman M, Zohar J, Kalian M, Belmaker R (1984) The effects of chronic lithium and ECT on A1 and A2 adenosine receptor systems in rat brain. Brain Res 291:188\u2013192","journal-title":"Brain Res"},{"key":"BF02246060_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(81)90031-5","volume":"71","author":"D Nutt","year":"1981","unstructured":"Nutt D, Cowen P, Green R (1981) Studies on the post-ictal rise in seizure threshold. Eur J Pharmacol 71:287\u2013295","journal-title":"Eur J Pharmacol"},{"key":"BF02246060_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(80)90156-9","volume":"61","author":"Y Okada","year":"1980","unstructured":"Okada Y, Kuroda Y (1980) Inhibitory action of adenosine and adenosine analogs on neurotransmission in the olfactory cortex slice of guinea pig: structure-activity relationships. Eur J Pharmacol 61:137\u2013146","journal-title":"Eur J Pharmacol"},{"key":"BF02246060_CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0304-3940(89)90554-5","volume":"101","author":"R Sanders","year":"1989","unstructured":"Sanders R, Murray T (1989) Temporal relationship between A1 adenosine receptor upregulation and alterations in bicuculline seizure susceptibility in rats. Neurosci Lett 101:325\u2013330","journal-title":"Neurosci Lett"},{"key":"BF02246060_CR40","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.1971.tb12037.x","volume":"18","author":"A Sattin","year":"1971","unstructured":"Sattin A (1971) Increase in the content of adenosine 3\u2032,5\u2032-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines. J Neurochem 18:1087\u20131096","journal-title":"J Neurochem"},{"key":"BF02246060_CR41","first-page":"265","volume-title":"Chemisms of the Brain","author":"A Sattin","year":"1981","unstructured":"Sattin A (1981) Adenosine as a mediator of antidepressant treatment. In: Rodnight R, et al. Chemisms of the Brain, Churchill-Livingstone, Edinburghff 265\u2013275"},{"key":"BF02246060_CR42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/0024-3205(88)90478-X","volume":"43","author":"T Seale","year":"1988","unstructured":"Seale T, Abla K, Shamim M, Carney J, Daly J (1988) 3,7-Dimethyl-1-propargylxanthine: a potent and selective in vivo antagonist of adenosine analogs. Life Sci 43:1671\u20131684","journal-title":"Life Sci"},{"key":"BF02246060_CR43","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1176\/ajp.144.9.1199","volume":"144","author":"B Shapira","year":"1987","unstructured":"Shapira B, Lerer B, Gilboa D, Drexler H, Kugelmass S, Calev A (1987) Facilitation of ECT by caffeine pretreatment. Am J Psychiatry 144:1199\u20131202","journal-title":"Am J Psychiatry"},{"key":"BF02246060_CR44","first-page":"58","volume":"1","author":"B Shapira","year":"1985","unstructured":"Shapira B, Zohar J, Newman M, Drexler H, Belmaker R (1985) Potentiation of seizure length and clinical response to electroconvulsive therapy by caffeine pretreatment: a case report. Convuls Ther 1:58\u201360","journal-title":"Convuls Ther"},{"key":"BF02246060_CR45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.ne.08.030185.000535","volume":"8","author":"S Snyder","year":"1985","unstructured":"Snyder S (1985) Adenosine as a neuromodulator. Annu Rev Neurosci 8:103\u2013124, 1985","journal-title":"Annu Rev Neurosci"},{"key":"BF02246060_CR46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-3956(84)90001-3","volume":"18","author":"S Snyder","year":"1984","unstructured":"Snyder S, Sklar P (1984) Behavioral and molecular actions of caffeine: focus on adenosine. J Psychiatr Res 18:91\u2013106","journal-title":"J Psychiatr Res"},{"key":"BF02246060_CR47","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0028-3908(87)90264-4","volume":"26","author":"P Szot","year":"1987","unstructured":"Szot P, Sanders R, Murray T (1987) Theophylline-induced upregulation of A1-adenosine receptors associated with reduced sensitivity to convulsants. Neuropharmacology 26:1173\u20131180","journal-title":"Neuropharmacology"},{"key":"BF02246060_CR48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00432761","volume":"77","author":"H Wachtel","year":"1982","unstructured":"Wachtel H (1982) Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3\u2032,5\u2032monophosphate phosphodiesterase inhibitors. Psychopharmacology 77:309\u2013316","journal-title":"Psychopharmacology"},{"key":"BF02246060_CR49","first-page":"42","volume":"265","author":"R Weir","year":"1983","unstructured":"Weir R, Hruska R (1983) Interaction between methylxanthines and the benzodiazepine receptor. Arch Int Pharmacodyn 265:42\u201348","journal-title":"Arch Int Pharmacodyn"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246060\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T22:23:27Z","timestamp":1586557407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF02246060"],"URL":"https:\/\/doi.org\/10.1007\/bf02246060","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}